Finance

Lists
301584:SHE
Shanghai C&D Innostic Medical Technology
CNÂ¥17.65
-0.95%
(-0.17) 1D
Oct 16, 3:04:16 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301584...
Open
CNÂ¥18.01
High
CNÂ¥18.34
Low
CNÂ¥17.52
Mkt. cap
7.77B
Avg. vol.
1.74M
Volume
1.96M
Dividend
1.13%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Sep 22, 2026
P/E ratio
26.43
52-wk high
CNÂ¥40.80
52-wk low
CNÂ¥17.52
EPS
CNÂ¥0.67
Shares outstanding
423.29M
No. of employees
2K
Open
CNÂ¥18.01
High
CNÂ¥18.34
Low
CNÂ¥17.52
Mkt. cap
7.77B
Avg. vol.
1.74M
Volume
1.96M
Dividend
1.13%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Sep 22, 2026
P/E ratio
26.43
52-wk high
CNÂ¥40.80
52-wk low
CNÂ¥17.52
EPS
CNÂ¥0.67
Shares outstanding
423.29M
No. of employees
2K
News stories
From web sources and news partners
About Shanghai C&D Innostic Medical Technology
CEO-
Employees2.12K
FoundedAug 30, 2010
Headquarters-
SectorHealth care provider
Websiteinnostic.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Mar 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.52B
5.03B
4.57B
4.52B
Cost of goods sold
4.15B
4.59B
4.27B
4.16B
Cost of revenue
4.15B
4.59B
4.27B
4.16B
Research and development expenses
5.02M
6.33M
9.35M
6.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
181.37M
202.93M
224.06M
179.12M
Operating expense
215.17M
213.23M
257.46M
208.23M
Total operating expenses
4.37B
4.81B
4.53B
4.37B
Operating income
147.53M
224.20M
42.04M
155.27M
Other non operating income
-3.95M
-68.47K
-5.86M
-1.64M
EBT including unusual items
81.64M
151.40M
61.79M
115.66M
EBT excluding unusual items
110.85M
193.23M
9.53M
132.49M
Income tax expense
21.19M
40.15M
10.69M
31.13M
Effective tax rate
25.96%
26.52%
17.31%
26.91%
Other operating expenses
5.83M
2.75M
15.94M
6.13M
Net income
49.21M
92.80M
39.80M
65.18M
Net profit margin
1.09%
1.84%
0.87%
1.44%
Earnings per share
-
-
-
-
Interest and investment income
2.19M
2.63M
1.41M
1.22M
Interest expense
-34.92M
-33.65M
-28.01M
-22.36M
Net interest expenses
-32.73M
-31.02M
-26.60M
-21.13M
Depreciation and amortization charges
-
-
-
-
EBITDA
155.41M
231.66M
52.10M
165.33M
Gain or loss from assets sale
-
306.51K
-2.12M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps